{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010/schedule/rule-4",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010/schedule/rule-4.json",
  "legislation": "uksi/2010/1616",
  "legislation_title": "The General Pharmaceutical Council (Statutory Committees and their Advisers Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010",
  "path": "schedule/rule/4",
  "kind": "rule",
  "number": "4",
  "heading": "Additional functions of the Investigating Committee",
  "text": "(1) The Investigating Committee has the following additional functions—\n(a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(b) providing advice to the Council about the content of any guidance to be issued by the Council about the circumstances in which allegations that have been referred to the Investigating Committee should be referred to the Fitness to Practise Committee;\n(c) determining whether or not disqualification allegations that have been referred to it should be referred to the Fitness to Practise Committee;\n(d) considering criminal conduct allegations referred to it by the Registrar; and\n(e) determining whether to notify the Registrar that the Council should consider exercising any of its powers to bring criminal proceedings in relation to—\n(i) criminal conduct allegations, and\n(ii) cases that have been referred to it as disqualification allegations.\n(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. rule 4(1)(a) omitted (5.2.2013) by virtue of The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 5(2)(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Sch. rule 4(1)(b) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 5(2)(b)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Sch. rule 4(1)(e) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 5(2)(c)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Sch. rule 4(2) omitted (5.2.2013) by virtue of The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 5(3)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 4 in force at 27.9.2010, see Sch. rule 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1616/schedule/rule/4",
    "retrieved_at": "2026-11-06T03:38:08.493928+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}